title: Product licences for alemtuzumab and multiple sclerosis.
authors.affiliation: Department of Clinical Neurosciences, University Neurology Unit, Cambridge CB2 0QQ, UK. Electronic address: ajc1020@medschl.cam.ac.uk.
authors.forename: Alasdair J
authors.initials: AJ
authors.lastname: Coles
authors.affiliation: Department of Clinical Neurosciences, University Neurology Unit, Cambridge CB2 0QQ, UK.
authors.forename: Alastair
authors.initials: A
authors.lastname: Compston
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D014481:United States
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab